Speaker

Prof Xiao graduated from Norman Bethune University of Medical Science, completed her medical training and her PhD at Chinese Medical University. She has been a postdoctoral fellow at Capital Medical University (Beijing, China) and Harvard School of Public Health (Boston, MA, USA).

She is currently the Director of Department of Tobacco Control and Prevention of Respiratory Disease and Deputy-Director of Respiratory Center, China-Japan Friendship Hospital, and Co-head of WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention. She is also the Chair of Beijing Tobacco Control Association, and Secretary-General and Standing Committee Member of China Tobacco Cessation Alliance. She also acts as senior principal investigator in China National Center for Respiratory Medicine, Institute of Respiratory Medicine of Chinese Academy of Medical Sciences, and National Clinical research Center for Respiratory Diseases.

Her research interests include tobacco control, multi-omics studies of respiratory diseases, and their prevention, with a focus on chronic obstructive pulmonary disease (COPD). She has published over 100 papers and served as the leading author of the Chinese Clinical Guidelines on Smoking Cessation (2007 and 2015 editions) and the China Report on Health Hazards of Smoking (2012 and 2020 editions). Her current investigations include studying the genetic heterogeneity of respiratory diseases like COPD between smokers and non-smokers, and integrating multi-omics data to develop precision prediction models for these conditions. She is actively designing precision treatment strategies for smoking cessation and smoking-related respiratory diseases, including COPD. Her research has significantly influenced clinical practice and policy for cessation treatment in China. As a clinician, she has treated several thousand dependent smokers and played a pivotal role in establishing a national tobacco cessation network in China and the Asia-Pacific region.